MURPHY ANDREW J — SEC Form 4 filings
SEC reporting owner CIK 1796226. 8 Form 4 filings on record with FilingPulse; latest filed 2025-12-11.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-15 to 2025-12-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 2 filings — 12,146 shares, $12,868,794 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 19.
- Largest priced transaction: sale of 1,016 shares @ $1,156.43 ($1,174,933) in REGENERON PHARMACEUTICALS, INC., filed 2024-08-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | EVP Research | 8 | — | 32 legs · 12,146 sh · $12,868,794 | 19 |
Form 4 filings — MURPHY ANDREW J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-12-11 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 4,229 @ $701.51 | EDGAR |
| 2025-12-09 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,715 @ $0 · Tax withholding (F): 1,699 @ $712.94 · Grant/award (A): 18,315 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 35,000 @ $555.67 · Tax withholding (F): 32,490 @ $648.82 · Gift (G): 1,538 @ $0 · Option exercise (M): 35,000 (derivative) @ $0 | EDGAR |
| 2024-12-18 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax withholding (F): 1,054 @ $730.81 | EDGAR |
| 2024-12-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 3,499 @ $0 · Tax withholding (F): 492 @ $787 · Grant/award (A): 13,472 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Gift (G): 1,185 @ $0 | EDGAR |
| 2024-08-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $399.66 · Tax withholding (F): 13,637 @ $1,141.49 · Sale (S): 55 @ $1,140.31 · Sale (S): 48 @ $1,142.94 · Sale (S): 79 @ $1,143.28 · Sale (S): 45 @ $1,144.89 · +15 more | EDGAR |
| 2024-03-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 20,000 @ $399.66 · Tax withholding (F): 14,217 @ $971.82 · Sale (S): 182 @ $951.92 · Sale (S): 444 @ $952.40 · Sale (S): 576 @ $953.77 · Sale (S): 870 @ $954.66 · +11 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1796226 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →